COMMUNIQUÉS West-GlobeNewswire

DBV Technologies invitée à Présenter à la Barclays Global Healthcare Conference
07/03/2018
Montrouge, France, le 7 mars, 2018 (7H30 CET) DBV Technologies invitée à Présenter à la Barclays Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) annonce [...]
Novartis expands alliance with Science 37 to advance virtual clinical trials program
07/03/2018
Novartis and Science 37 commit to launch up to 10 trials with increasing decentralization over three years, scaling to "site-less" model Agreement builds on our long-standing investment in and collaboration with Science [...]
Bone Therapeutics Announces Private Placement of Convertible Bonds
07/03/2018
Regulated Information - Inside Information - 7 March 2018 - 7 am CET NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, [...]
Bone Therapeutics annonce un placement privé sous forme d'obligations convertibles:
07/03/2018
Information réglementée - Information confidentielle - 7 mars 2018 - 7h00 CET LE PRÉSENT COMMUNIQUÉ NE DOIT PAS ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, TOTALEMENT OU PARTIELLEMENT, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS- [...]
Mesoblast Enters Into US$75 Million Non-Dilutive Credit Facility
07/03/2018
MELBOURNE, Australia and NEW YORK, March 06, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) today announced that it has entered into a US$75 million non-dilutive, four-year credit facility with [...]
Sonoma Pharmaceuticals Announces Closing of $5 Million Public Offering of Common Stock
07/03/2018
PETALUMA, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, Warrants – SNOAW) today announced the closing of a public offering of 1,428,570 shares of common stock at a public [...]
Syneos Health to Present at Upcoming Barclays Global Healthcare Conference
06/03/2018
RALEIGH, N.C., March 06, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald is [...]
IHMA Completes the Globalization of its Two Laboratories with the Recent College of American Pathologists (CAP) Accreditation of IHMA Europe, Enhancing Support for Clinical Trials in Anti-Infective Drug Development and Global Surveillance Studies
06/03/2018
SCHAUMBURG, Ill., March 06, 2018 (GLOBE NEWSWIRE) -- On 14th October 2017 IHMA Europe Sàrl, located in Monthey, Valais, Switzerland, was awarded accreditation by the College of American Pathologists (CAP). With this [...]
REVA to Present at Cowen and Company 38th Annual Health Care Conference
06/03/2018
SAN DIEGO, March 06, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that its Chief Financial Officer, Ms. Brandi Roberts, is scheduled to present at the Cowen and [...]
iKang Schedules 2017 Unaudited Third Quarter Earnings Release on March 22, 2018
06/03/2018
BEIJING, March 06, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), major provider in China’s fast-growing private preventive healthcare services market, today announced [...]
Proteon Therapeutics to Present at Two Upcoming Investor Conferences
06/03/2018
WALTHAM, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO ), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results, Highlights Achievements and Key 2018 Milestones
06/03/2018
Achieved positive results of Eravacycline in Phase 3 IGNITE 4 clinical trial for cIAI Filed NDA in US for IV Eravacycline for cIAI and PDUFA date is August 28 th Raised over $65 million through underwritten equity [...]
ReWalk Robotics to Present at Upcoming Healthcare Conferences
06/03/2018
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK ) (“ReWalk” or “the Company”) today announced that Larry Jasinski, Chief Executive Officer, will present [...]
Switching clocks can wreak havoc on our sleep patterns
06/03/2018
CALGARY, Alberta, March 06, 2018 (GLOBE NEWSWIRE) -- Charles H. Samuels MD, CCFP, DABSM President, Canadian Sleep Society, Medical Director, Centre for Sleep and Human Performance Daylight Savings Time begins this [...]
Reprocessed VNUS ClosureFast Catheters – 6 Years of Superior Performance
06/03/2018
WATERBURY, Conn., March 06, 2018 (GLOBE NEWSWIRE) -- Northeast Scientific Inc. (NES) has released 5-year results proving that the use of their reprocessed medical devices is safe, effective and smart. NES has [...]
Aeglea BioTherapeutics to Present Adult Repeat Dose Data at 2018 Annual Meeting of The Society for Inherited Metabolic Disorders
06/03/2018
AUSTIN, Texas, March 06, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]
Globus Medical Enters Trauma Market
06/03/2018
AUDUBON, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, is pleased to announce its entry into the orthopedic trauma market. Globus Medical has [...]
Supernus to Present at the 2018 Cowen Health Care Conference
06/03/2018
ROCKVILLE, Md., March 06, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central [...]
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
06/03/2018
WAYNE, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]

Pages